About: Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report
Creator	Brindley, Peter Karakitsos, Dimitrios Alharthy, Abdulrahman Alshaya, Rayan Faqihi, Fahad Kutsogiannis, Demetrios Papanikolaou, John
Source	Medline; PMC
abstract	BACKGROUND: Fulminant (life-threatening) COVID-19 can be associated with acute respiratory failure (ARF), multi-system organ failure and cytokine release syndrome (CRS). We present a rare case of fulminant COVID-19 associated with reverse-takotsubo-cardiomyopathy (RTCC) that improved with therapeutic plasma exchange (TPE). CASE PRESENTATION: A 40 year old previous healthy male presented in the emergency room with 4 days of dry cough, chest pain, myalgias and fatigue. He progressed to ARF requiring high-flow-nasal-cannula (flow: 60 L/minute, fraction of inspired oxygen: 40%). Real-Time-Polymerase-Chain-Reaction (RT-PCR) assay confirmed COVID-19 and chest X-ray showed interstitial infiltrates. Biochemistry suggested CRS: increased C-reactive protein, lactate dehydrogenase, ferritin and interleukin-6. Renal function was normal but lactate levels were elevated. Electrocardiogram demonstrated non-specific changes and troponin-I levels were slightly elevated. Echocardiography revealed left ventricular (LV) basal and midventricular akinesia with apex sparing (LV ejection fraction: 30%) and depressed cardiac output (2.8 L/min) consistent with a rare variant of stress-related cardiomyopathy: RTCC. His ratio of partial arterial pressure of oxygen to fractional inspired concentration of oxygen was < 120. He was admitted to the intensive care unit (ICU) for mechanical ventilation and vasopressors, plus antivirals (lopinavir/ritonavir), and prophylactic anticoagulation. Infusion of milrinone failed to improve his cardiogenic shock (day-1). Thus, rescue TPE was performed using the Spectra Optia™ Apheresis System equipped with the Depuro D2000 Adsorption Cartridge (Terumo BCT Inc., USA) without protective antibodies. Over 5 days he received daily TPE (each lasting 4 hours). His lactate levels, oxygenation, and LV function normalized and he was weaned off vasopressors. His inflammation markers improved, and he was extubated on day-7. RT-PCR was negative on day-17. He was discharged to home isolation in good condition. CONCLUSION: Stress-cardiomyopathy may complicate the course of fulminant COVID-19 with associated CRS. If inotropic therapy fails, TPE without protective antibodies may help rescue the critically ill patient.
has issue date	2020-08-26(xsd:dateTime)
bibo:doi	10.1186/s12872-020-01665-0
bibo:pmid	32842957
has license	cc-by
sha1sum (hex)	a7df548af01018fad443d3e345eaf30c21061510
schema:url	https://doi.org/10.1186/s12872-020-01665-0
resource representing a document's title	Reverse takotsubo cardiomyopathy in fulminant COVID-19 associated with cytokine release syndrome and resolution following therapeutic plasma exchange: a case-report
has PubMed Central identifier	PMC7447602
has PubMed identifier	32842957
schema:publication	BMC Cardiovasc Disord
resource representing a document's body	covid:a7df548af01018fad443d3e345eaf30c21061510#body_text
is schema:about of	named entity 'improve' named entity 'inspired' named entity 'flow' named entity 'Terumo' named entity 'levels' named entity 'arterial pressure' named entity 'progressed' named entity 'System' named entity 'cytokine release syndrome' named entity 'CONCENTRATION OF' named entity 'OXYGEN' named entity 'APHERESIS SYSTEM' named entity 'INTERSTITIAL INFILTRATES' named entity 'VASOPRESSORS' named entity 'CANNULA' named entity 'BUT' named entity 'INFLAMMATION' named entity 'RTCC' named entity 'GOOD' named entity 'BACKGROUND' named entity 'DRY COUGH' named entity 'MYALGIAS' named entity 'PREVIOUS' named entity 'FERRITIN' named entity 'BIOCHEMISTRY' named entity 'POLYMERASE-CHAIN-REACTION' named entity 'I LEVELS' named entity 'REVEALED' named entity 'ADMITTED TO' named entity 'FAILED' named entity 'ACUTE RESPIRATORY FAILURE' named entity 'HEALTHY' named entity 'PROGRESSED' named entity '4 HOURS' named entity 'DEMONSTRATED' named entity 'YEAR' named entity 'ISOLATION' named entity 'RELATED' named entity 'TPE' named entity 'His' named entity 'emergency room' named entity 'elevated' named entity 'Echocardiography' named entity 'antivirals' named entity 'anticoagulation' named entity 'left ventricular' named entity 'milrinone' named entity 'confirmed' named entity 'fulminant' named entity 'improved' named entity 'acute respiratory failure' named entity 'assay' named entity 'RT-PCR' named entity 'chest X-ray' named entity 'oxygen' named entity 'fraction of inspired oxygen' named entity 'Electrocardiogram' named entity 'lactate dehydrogenase' named entity 'protective antibodies' named entity 'prophylactic' named entity 'vasopressors' named entity 'COVID-19' named entity 'cardiogenic shock' named entity 'fatigue' named entity 'Fulminant' named entity 'lopinavir/ritonavir' named entity 'ARF' named entity 'COVID-19' named entity 'dopamine' named entity 'Apheresis' named entity '1.1' named entity 'acute heart failure' named entity '28 days' named entity 'viremia' named entity 'neurocardiogenic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software